Pier Paolo Piccaluga, MD, PhD¹, Anna Gazzola, PhD^1*, Ying Huang^2*, Jeff Panganiban^2*, Kasey Hutt^2* and Michael Klass^2*

¹DIMES, University of Bologna, Bologna, Italy
²Invivoscribe Technologies, Inc., san diego, CA

Sung-Nan Pei, MD^1*, Ming-Chung Wang, MD^1*, Ming-Chung Ma, MD^1*, Ching-Yuan Kuo, MD,^2*, Chien-Hung Chen^3* and Po-Nan Wang, MD⁴

¹Division of Hematology/Oncology, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan
²Chang Gung Memorial Hospital at Kaohsiung, Kaohsiung, Taiwan
³Division of Hepatogastroenterology, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan
⁴Chang Gung Memorial Hospital-Linkou, Taoyuan, Taiwan

Xin-xin Cao, MD^1*, Jian Sun, MD^2*, Jian Li, MD^1*, Ding-rong Zhong, MD^2*, Na Niu, Bachelor^3*, Ming-hui Duan, MD^1*, Zhi-yong Liang, MD^2* and Dao-bin Zhou, MD^1*

¹Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
²Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
³Department of Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China

Sara Alonso, MD^1*, Miguel Alcoceba^2*, Oscar Blanco^3*, Julio Davila, MD^1*, Juan Carlos Caballero, MD^4*, Luis Garcia^5*, Oscar Ferre^5*, Felix Lopez-Cadenas^6*, Nerea Arratibel^6*, Alvaro Veiga^5*, Monica Baile^6*, Oriana Lopez^7*, Estefania Perez^7*, Maria Dolores Caballero, MD, PhD^8*, Marcos González, MD, PhD^2*, Consuelo Del Cañizo, MD, PhD^1,9, Maria Belen Vidriales, MD, PhD^1* and Alejandro Martin, MD, PhD^5*

¹Department of Hematology, Hospital Universitario de Salamanca, Salamanca, Spain
²Hospital Clínico Universitario de Salamanca, Salamanca, Spain
³Pathology Department, University Hospital of Salamanca, Salamanca, Spain
⁴Hematology, Salamanca Universitary Hospital, Salamanca, Spain
⁵Universitiy Hospital of Salamanca, Salamanca, Spain
⁶University Hospital of Salamanca, Salamanca, Spain
⁷Hematology Department, Hospital Clínico Universitario de Salamanca, IBSAL, Salamanca, Spain
⁸Universitiy Hospital of Salamanca, Universitiy Hospital of Salamanca, Salamanca, Spain
⁹Instituto Biosanitario de Salamanca (IBSAL) and Cancer Research Centre (Instituto de Biología Molecular y Celular del Cáncer; CSIC-USAL), Salamanca, Spain

Marie-Helene Delfau-Larue, MD, PhD^1,2,3*, Isabelle Nel, PD^2*, Axel VAN Der Gucht, MD^3,4*, Gaelle Laboure, MD^5*, Benjamin Verret, MD^5*, Salma Hamdane, PD^2*, Philippe Gaulard, MD, PhD^1,3,6*, Michel Meignan, MD, PhD^3,4*, Corinne Haioun, MD, PhD^3,7, Christiane Copie-Bergman, MD, PhD^3,6,8*, Jehan Dupuis, MD^5* and Emmanuel Itti, MD, PhD^3,4*

¹EQ 9, INSERM U955, CRETEIL, France
²Department of Biological Hematology and immunology, APHP, Groupe Hospitalier Mondor, CRETEIL, France
³UPEC University, CRETEIL, France
⁴Nuclear Medicine Department, APHP, Groupe Hospitalier Mondor, CRETEIL, France
⁵Lymphoid Malignancies Unit, APHP, Groupe Hospitalier Mondor, CRETEIL, France
⁶department of pathology, APHP, Groupe Hospitalier Mondor, CRETEIL, France
⁷Lymphoid Malignancies Unit, AP-HP, Groupe Hospitalier Mondor, Créteil, France
⁸EQ 9, INSERM U955, CRETEIL, France

Joshua Allen, Ph.D.^1*, Rohinton Tarapore, Ph.D.^1*, Mathew J Garnett, Ph.D.^2* and Cyril Benes, Ph.D.^3*

¹Oncoceutics, Inc, Hummelstown, PA
²Wellcome Trust Sanger Institute, Cambridge, United Kingdom
³Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA

Maria Joao Baptista, PharmD, PhD^1*, Gustavo Tapia, MD^2*, Ana-Maria Muñoz-Marmol, PhD^2*, Olga Garcia, MD^3*, Josep Muncunill, MSc^1*, Maria-Jose Terol, MD, PhD^4*, Eva González-Barca, MD, PhD^5*, Pilar Miralles, MD, PhD^6*, Ferran Vall-Llovera, MD^7*, Mariano Provencio, MD, PhD^8*, Miriam Moreno, MD^1*, Juan-Manuel Sancho, MD, PhD^3*, Jose-Luis Mate, MD, PhD^2*, Evarist Feliu, MD, PhD^1*, Josep-Maria Ribera, MD, PhD¹ and Jose-Tomas Navarro, MD, PhD^1*

¹Hematology Department, ICO- Hospital Universitari Germans Trias i Pujol, Josep Carreras Leukaemia Research Institute, Badalona, Spain
²Pathology Department, Hospital Universitari Germans Trias i Pujol, Badalona, Spain
³Department of Hematology, ICO Badalona-Hospital Germans Trias i Pujol. Josep Carreras Leukemia Research Institute. Universitat Autònoma de Barcelona, Badalona, Spain
⁴Servicio de Hematología y Oncología Médica, Hospital Clínico Universitario de Valencia, Valencia, Spain
⁵Hematology Department, ICO-Hospital Duran i Reynals, Barcelona, Spain
⁶Hospital Gregorio Marañón, Madrid, Spain
⁷Servicio de Hematología Clínica, Hospital Universitari Mutúa de Terrassa, Terrassa, Spain
⁸Department of Medical Oncology, University Hospital Puerta De Hierro, Madrid, Spain

Jessica I Hoell, MD^1*, Kunal Das Mahapatra^1*, Kebria Hezaveh^1*, Andreas Kloetgen^1*, Stephan Bernhart^2*, Steve Hoffmann^2*, Peter Stadler^2*, Dido Lenze^3*, Andrea Haake^4*, Julia Richter^4*, Lorenz H. Truemper, MD, PhD⁵, Birgit Burkhardt^6*, Wolfram Klapper, MD^7*, Peter Moeller, MD, PhD⁸, Philip Rosenstiel^9*, Chris Lawerenz^10*, Roland Eils^10*, Reiner Siebert, MD^4*, Michael Hummel, PhD^3* and Arndt Borkhardt, MD¹

¹Heinrich-Heine-University, Medical Faculty, Department of Pediatric Oncology, Hematology and Clinical Immunology, Duesseldorf, Germany
²Transcriptome Bioinformatics, LIFE Research Center for Civilization Diseases, Leipzig, Germany
³Charité – University Medicine Berlin, Institute of Pathology, Berlin, Germany
⁴Christian-Albrechts-University Kiel, Institute of Human Genetics, Kiel, Germany
⁵Hematology and Oncology, University Medicine Goettingen, Goettingen, Germany
⁶Pediatric Hematology and Oncology, University Hospital Muenster, Muenster, Germany
⁷Hematopathology Section, Christian-Albrechts-University Kiel, Kiel, Germany
⁸Institute of Pathology, University of Ulm, Ulm, Germany
⁹Christian-Albrechts-University Kiel, Institute of Clinical Molecular Biology, Kiel, Germany
¹⁰Division Theoretical Bioinformatics, Deutsches Krebsforschungszentrum Heidelberg (DKFZ), Heidelberg, Germany

Barila' Gregorio, MD^1,2*, Antonella Teramo, PhD^1,2*, Giulia Calabretto, BS^1,2*, Chiara Ercolin, BS^1,2*, Albana Lico, MD^1*, Antonio Branca, MD^1*, Tamara Berno, MD^1*, Anna Cabrelle, BS^2*, Elisa Boscaro, BS^1*, Monica Facco, MS^1,2*, Livio Trentin, MD^1,2, Francesco Piazza, MD^1,2, Gianpietro Semenzato^2,3* and Renato Zambello^1,2*

¹Department of Medicine, Hematology and Clinical Immunology Section, Padua University School of Medicine, Padua, Italy
²Venetian Institute of Molecular Medicine (VIMM), Padua, Italy
³Department of Medicine, Hematology and Clinical Immunology, Padua School of Medicine, Padova, Italy

Tsutomu Kobayashi, MD, PhD^1*, Junya Kuroda, MD, PhD^1*, Isao Yokota, PhD^2*, Kazuna Tanba, MD^1*, Tomohiko Taki, MD, PhD³, Takahiro Fujino, MD^4*, Saeko Kuwahara, MD^4*, Reiko Isa, MD^5*, Junko Yamaguchi, MD^5*, Eri Kawata, MD, PhD^5*, Teruaki Akaogi, MD^5*, Hitoji Uchiyama, MD, PhD^4*, Hiroto Kaneko, MD^6*, Nobuhiko Uoshima, MD, PhD^5*, Yutaka Kobayashi, MD, PhD^5*, Satoshi Teramukai, PhD^2* and Masafumi Taniwaki^1*

¹Division of Hematology and Oncology, Kyoto Prefectural University of Medicine Graduate School of Medical Science, Kyoto, Japan
²Department of Biostatistics, Kyoto Prefectural University of Medicine Graduate School of Medical Science, Kyoto, Japan
³Department of Molecular Diagnostics and Therapeutics, Kyoto Prefectural University of Medicine Graduate School of Medical Science, Kyoto, Japan
⁴Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan
⁵Department of Hematology, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan
⁶Department of Hematology, Aiseikai Yamashina Hospital, Kyoto, Japan

Rathana Kim^1*, Myrto Costopoulos, PharmD^1*, Sylvain Choquet, MD^2*, Karim Maloum, MD, PhD¹, Caroline Algrin, MD^2*, Khe Hoang-Xuan, MD, PhD^3*, Catherine Settegrana, PharmD^1*, Juliette Villemonteix^1*, Martine Brissard^1*, Frederic Davi, MD, PhD^1*, Veronique Leblond, MD², Helene Merle-Beral, MD, PhD¹ and Magali Le Garff-Tavernier, PharmD, PhD^1*

¹Department of Biological Hematology, Pitie-Salpetriere Hospital and Pierre et Marie Curie University, Paris, France
²Department of Clinical Hematology, Pitie-Salpetriere Hospital and Pierre et Marie Curie University, Paris, France
³Department of Neurology, Pitie-Salpetriere Hospital and Pierre et Marie Curie University, Paris, France

Wenjie Xiong^1*, Heng Li^1*, Shuhua Yi^1*, Zengjun Li Sr.^1*, Shizhen Zhong^1*, Wei Liu^1*, Rui Lv^1*, Dehui Zou^2* and Lugui Qiu, MD, PhD³

¹State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China
²Institute of Hematology and Blood Disease Hospital,, Chinese Academy of Medical Sciences and Peking Union Medical College, tianjin, China
³State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin, China

Patricia Johansson, MD^1,2*, Jan Dürig, MD^2*, Jan Rekowski, Dipl.-Stat.^3*, Stefan P Müller, MD^4*, Bernd Hertenstein, MD^5*, Christiane Franzius, MD^6*, Frank Kroschinsky, MD⁷, Jörg Kotzerke, MD^8*, Rolf Mesters, MD⁹, Matthias Weckesser, MD^10*, Paul La Rosée, Prof. Dr. med.^11*, Martin Freesmeyer, MD^12*, Stefan Wilop, MD^13*, Thomas Krohn, MD^14*, Ulrich Dührsen, MD² and Andreas Hüttmann, MD²

¹Institute of Cell Biology (Cancer Research), University Hospital Essen, Faculty of Medicine, University of Duisburg-Essen, Essen, Germany
²Department of Haematology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany
³Institute for Medical Informatics, Biometry and Epidemiology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany
⁴Department of Nuclear Medicine, University Hospital Essen, University of Duisburg-Essen, Essen, Germany
⁵I. Medizinische Klinik, Klinikum Bremen-Mitte, Bremen, Germany
⁶Center for Modern Diagnostics, Klinikum Bremen Mitte, Bremen, Germany
⁷Internal Medicine I,, University Hospital Carl Gustav Carus, Dresden, Germany
⁸Nuclear Medicine, University Hospital Carl Gustav Carus, Dresden, Germany
⁹Department of Internal Medicine A, University Hospital Münster, Münster, Germany
¹⁰Department of Nuclear Medicine, University Hospital Münster, Münster, Germany
¹¹Klinik für Innere Medizin II, Abt. Hämatologie u. internist. Onkologie, Jena University Hospital, Jena, Germany
¹²Department of Nuclear Medicine, University Hospital Jena, Jena, Germany
¹³Department of Internal Medicine IV, University Hospital Aachen, Aachen, Germany
¹⁴Department of Nuclear Medicine, University Hospital Aachen, Aachen, Germany

Ritsuko Seki¹, Takashi Okamura², Koteda Satoko^3*, Kuniki Kawaguchi^1*, Kei Noumura^4*, Takayuki Nakamura^1*, Harumi Takeda^1*, Satoshi Morishige^4*, Fumihiko Mouri^1*, Koichi Osaki^1*, Ohshima Koichi^5* and Koji Nagafuji¹

¹Division of Hematology and Oncology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan
²Center for Hematology and Oncology, St. Mary's Hospital, Kurume, Japan
³Division of Hematology and Oncology/Department of Medicine,, Kurume University School of Medicine, Kurume, Japan
⁴Division of Hematology and Oncology, Department of Medicine,, Kurume University School of Medicine, Kurume, Japan
⁵Department of Pathology, Kurume University School of Medicine, Kurume, Japan

Keisuke Kataoka, MD, Ph.D.^1*, Yasunobu Nagata, MD, Ph.D.^1*, Akira Kitanaka, MD, PhD², Yuichi Shiraishi, MD, Ph.D.^3*, Yasushi Totoki^4*, Jun-ichirou Yasunaga, MD, PhD⁵, Kenichi Chiba, BA^3*, Aiko Sato-Otsubo, PhD^1*, Masashi Sanada, MD, Ph.D.^6*, Hiroko Tanaka, BA^3*, Yusuke Shiozawa, MD^1*, Tetsuichi Yoshizato, MD^1*, Kenichi Yoshida, MD, Ph.D.^1*, Hideki Makishima, MD, Ph.D.¹, Masakatsu Hishizawa^7*, Hidehiro Itonaga, MD, PhD^8*, Yoshitaka Imaizumi, MD, PhD^9*, Wataru Munakata, MD^10*, Nakamura Hiromi^4*, Natsuko Hama^4*, Kotaro Shide, MD, PhD², Yoko Kubuki^2*, Tomonori Hidaka^2*, Takuro Kameda^2*, Tsuyoshi Nakamaki, MD¹¹, Kensei Tobinai, MD, PhD¹², Yasushi Miyazaki, MD, Ph.D.⁹, Akifumi Takaori-Kondo, MD, PhD⁷, Masao Matsuoka, MD, PhD⁵, Tatsuhiro Shibata^4*, Satoru Miyano, MD, Ph.D.^3*, Kazuya Shimoda, MD, PhD² and Seishi Ogawa, MD, Ph.D.¹

¹Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
²Department of Gastroenterology and Hematology, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan
³Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan
⁴Division of Cancer Genomics, National Cancer Center Research Institute, Tokyo, Japan
⁵Laboratory of Virus Control, Institute for Virus Research, Kyoto University, Kyoto, Japan
⁶Department of Advanced Diagnosis, Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan
⁷Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
⁸Department of Hematology, Sasebo City General Hospital, Sasebo, Japan
⁹Department of Hematology, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan
¹⁰Department of Hematology, National Cancer Center Hospital, Tokyo, Japan
¹¹Division of Hematology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan
¹²National Cancer Center Hospital, Tokyo, Japan

Athena Kritharis, MD^1*, J. Tyson McDonald, PhD^2*, Afshin Beheshti, PhD^3*, Monika Pilichowska, MD^4*, Kristine Burgess, DVM, MS^5*, Luisel Ricks-Santi, PhD^2*, Elizabeth McNiel, DVM, PhD^5*, Ravi Dashnamoorthy, PhD³ and Andrew M. Evens, DO, MSc¹

¹Division of Hematology/Oncology, Tufts Medical Center, Boston, MA
²Cancer Research Center, Hampton University, Hampton, VA
³Molecular Oncology Research Institute, Tufts Medical Center, Boston, MA
⁴Division of Pathology, Tufts Medical Center, Boston, MA
⁵Cummings School of Veterinary Medicine, Tufts University, Boston, MA

Nakayama Shoko^1*, Tsuji Motomu^2*, Yokote Taiji^1*, Akioka Toshikazu^1*, Miyoshi Takuji^1*, Hiraoka Nobuya^1*, Hirata Yuji^1*, Iwaki Kazuki^1*, Takayama Ayami^1*, Nishiwaki Uta^1*, Masuda Yuki^1*, Hatooka Jun^1*, Hanafusa Toshiaki^1* and Nishikawa Hiroyoshi^3*

¹Internal Medicine (I), Osaka Medical College, Takatsuki City, Japan
²Surgical Pathology, Osaka Medical College, Takatsuki City, Japan
³Office of Translational Research, National Cancer Center, Chiba City, Japan

Luis Porrata, MD¹, Kay Ristow^1*, Ellen D. McPhail, MD², William Macon, MD^1*, Matthew J Maurer, MS³, Grzegorz S. Nowakowski, MD⁴, Stephen Ansell, MD, PhD¹, Thomas E. Witzig, MD⁵, Svetomir Markovic, MD, PhD¹ and Thomas M. Habermann, MD⁴

¹Mayo Clinic, Rochester, MN
²Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
³Department of Health Sciences Research, Mayo Clinic, Rochester, MN
⁴Division of Hematology, Mayo Clinic, Rochester, MN
⁵Mayo Clinic Rochester, Rochester

Akira Satou, MD, Ph.D.^1*, Naoko Asano, MD, Ph.D.², Seiichi Kato, MD, Ph.D.^1*, Ahmed Ali Elsayed, MD^1,3*, Naoya Nakamura, MD, Ph.D.^4*, Koichi Ohshima, MD, PhD^5* and Shigeo Nakamura, MD, Ph.D.⁶

¹Department of Pathology and Laboratory Medicine, Nagoya University Hospital, Nagoya, Japan
²Department of Clinical Laboratory, Nagano Prefectural Suzaka Hospital, Suzaka, Japan
³Department of Pathology, Faculty of Medicine, Mansoura University, Mansoura, Egypt
⁴Department of Pathology, Tokai University School of Medicine, Isehara, Japan
⁵Department of Pathology, Kurume University, School of Medicine, Kurume, Japan
⁶Adult Lymphoma Treatment Study Group (ALTSG), Nagoya, Japan

Christine F. Skibola, PhD

University of Alabama, Birmingham, Birmingham, AL

Rita Coutinho, MD, PhD^*, Joana Lobato, MD^*, Susana Esteves^*, Susana Carvalho, MD^*, Francesca Pierdomenico, MD^*, Paulo Bernardo, MD^*, Filipe Gonçalves, MD^*, Joana Desterro, MD^*, Soraia Martins^*, Carla Silva^* and Maria Gomes Silva, MD, PhD

Hematology Department, Portuguese Institute of Oncology Lisbon, Lisbon, Portugal

Anna Dodero, MD^1*, Francesco Maura, MD^2*, Alessio Pellegrinelli, MD^3*, Antonello Cabras, MD^3*, Annalisa Chiappella, MD⁴, Domenico Novero, MD^5*, Federico Vittone, MD^6*, Francesco Zaja, MD⁷, Stefano Pizzolitto, MD^8*, Cristiana Carniti, PhD^2*, Alessandra Cavane'^1*, Martina Pennisi, MD^1*, Umberto Vitolo, MD⁴, Niccolo' Bolli, MD^1* and Paolo Corradini²

¹Department of Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy
²Department of Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
³Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
⁴Department of Hematology, Azienda Ospedaliera Città della Salute e della Scienza, Torino, Italy
⁵Patology Unit, Città della Salute Hospital and University, Torino, Italy
⁶Department of Pathology, Citta’ della Salute e della Scienza, Torino, Torino, Italy
⁷Clinica Ematologica, DRMM, Azienda Ospedaliero Universitaria, Udine, Italy
⁸Pathology Service, DRMM, Azienda Ospedaliero Universitaria, Udine, Italy

Katharina Troppan, MD^1*, Kerstin Wenzl, MSc^1*, Peter Neumeister, MD^2*, Christine Beham-Schmid, MD^3*, Martina Przekopowitz^4*, Hildegard T. Greinix, MD⁵, Helmut Schaider, MD^6* and Alexander JA Deutsch, PhD^1*

¹Internal Medicine / Hematology, Medical University Graz, Graz, Austria
²Internal Medicine / Hematology, Medical Universitiy of Graz, Graz, Austria
³Pathology, Medical University Graz, Graz, Austria
⁴Cell Biology, University of Duisburg-Essen, Duisburg, Germany
⁵Hematology, Medical University Graz, Graz, Austria
⁶Dermatology Research Centre, The University of Queensland, Queensland, Australia

Miyoshi Hiroaki, MD, PhD^1*, Junichi Kiyasu, MD^2*, Takeharu Kato, MD^3*, Noriaki Yoshida, MD, PhD^1*, Daisuke Kurita, MD^1*, Sasaki Yuya, MD^1*, Koji Kato, MD, PhD^4*, Yoshitaka Imaizumi, MD, PhD^3*, Masao Seto, MD, PhD¹, Koichi Akashi, MD, PhD^5* and Koichi Ohshima, MD, PhD^1*

¹Department of Pathology, Kurume University, School of Medicine, Kurume, Japan
²Department of Medicine and Bioregulatory Science, Kyushu University, Graduate School of Medical Sciences, Fukuoka, Japan
³Department of Hematology, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan
⁴Department of Medicine and Biosystemic Science, Kyushu University, Faculty of Medicine, Fukuoka, Japan
⁵Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan

Mahasweta Gooptu, MD^1*, Alina E Dulau Florea, MD^2*, Benjamin E Leiby, PhD^3*, Barbara Pro⁴, John David Sprandio Jr., MD^5*, Diana whittaker-Menezes^6*, Paolo Cotzia, MD^7*, Guldeep Uppal, MD^8*, Jaime Caro, MD⁹, Jerald Gong, MD^8* and Ubaldo Martinez-Outschoorn, M.D.^6*

¹Medical Oncology, Thomas Jefferson University, Philadelphia, PA
²National Institutes of Health, Bethesda, MD
³Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia, PA
⁴Thomas Jefferson University, Philadelphia, PA
⁵Mainline Health/Bryn Mawr Hospital, Consultants in Medical Oncology and Hematology, INC, Drexel Hill, PA
⁶Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA
⁷Pathology, Thomas Jefferson University, Philadelphia, PA
⁸Hematopathology, Thomas Jefferson University, Philadelphia, PA
⁹Hematology and Medical Oncology, Cooper University Healthcare, Camden, NJ

Colm Keane, MB BCh BAO MSc MBA MRCPI FRCPath FRCPA PhD^1,2*, Kimberly Jones, PhD^2*, Clare Gould, MBBS^2*, David Hamm^3*, Peter Wood, MD, FRACP, FRCPA, MBBS^4*, Simone Birch, FRCPA PhD^4*, Pauline Crooks, BSc^2*, Michael R Green, Ph.D.⁵, Dipti Taulaulikar, MBBS, PhD, FRACP, FRCPA,^6*, Sanjiv Jain, FRCPA^6*, Josh Tobin, MBBS^7* and Maher K Gandhi, PhD FRACP FRCPath FRCP⁸

¹Haematology, Princess Alexandra Hospital, Brisbane, Australia
²Translational Research Institute, UQDI, Brisbane, Australia
³Adaptive Biotechnology, Seatlle
⁴Princess Alexandra Hospital, Brisbane, Australia
⁵University of Nebraska Medical Centre, Eppley Institute, Omaha
⁶Australian National University, Canberra, Australia
⁷Mater Hospital, Brisbane, Australia
⁸Diamantina Institute, University of Queensland, Brisbane, Australia

Sedat Demirdas^1*, Lewin Eisele, MD^2*, Jörg Hense, MD^3*, Ulrich Dührsen, MD¹ and Andreas Hüttmann, MD¹

¹Department of Haematology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany
²Institute for Medical Informatics, Biometry and Epidemiology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany
³Department of Medical Oncology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany

Tingxun Lu, MD, PhD,^1,2*, Yi Miao^3*, Jia-Zhu Wu, MD, PhD,^1*, Qi-Xing Gong^4*, Jin-Hua Liang^3*, Zhen Wang^4*, Li Wang^3*, Lei Fan, MD., PhD.^3*, Yao-Yu Chen^1*, Zhi-Hong Zhang^4*, Wei Xu^3* and Jian-Yong Li, MD, PhD^3,5

¹Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, nanjing, China
²Department of Oncology, Affiliated Hospital of Jiangnan University, wuxi, China
³Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China
⁴Department of Pathology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, nanjing, China
⁵Collaborative Innovation Center For Cancer Personalized Medicine, Nanjing Medical University, nanjing, China

David G. Coffey, MD,^1,2, Katharine A. Lombardo, BS^2,3*, Andrea M. H. Towlerton, BS^2*, Sarah E. Gerdts, MPH^4*, Corey Casper, MD,^4,5*, Jackson Orem, MD^5,6 and Edus H. Warren III, MD, PhD^1,2

¹Department of Medicine, University of Washington, Seattle, WA
²Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
³Molecular and Cellular Biology Graduate Program, University of Washington, Seattle, WA
⁴Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA
⁵UCI/Hutchinson Center Cancer Alliance, Kampala, Uganda
⁶Uganda Cancer Institute, Kampala, Uganda

Saad M B Rassam, MD, FRCP, FRCPath¹, John Schofield, FRCPath^2*, Farooq Malik, PhD^3*, Azim M Mohamedali, PhD^4*, Bartlomiej Przychodzen, MSc^5*, Gabrielle Elstein^6* and Ghulam J Mufti, FRCP, FRCPath⁷

¹Haematology, Kent Oncology Centre, Maidstone, United Kingdom
²Histopathology, Maidstone Hospital, Maidstone, United Kingdom
³Haematological Medicine, Kings College Hospital, London, United Kingdom
⁴Haematological Medicine, Kings College London, London, United Kingdom
⁵Haematological Medicine, Department of Translational hematology and Oncology Research, Taussing Cancer Institute, Cleveland Clinic, London, United Kingdom
⁶Advanced Diagnostics, University College Hospital, London, United Kingdom
⁷Department of Haematological Medicine, King’s College London, London, United Kingdom

Samantha Morley, PhD^1*, Jie He, PhD^1*, Andrew M. Intlekofer, MD, PhD², Mark Bailey, MS^1*, Michelle Nahas, PhD^1*, Doron Lipson, PhD^1*, Roman Yelensky, PhD^1*, Jeffrey Ross, MD^1*, Siraj Ali, MD, PhD^1*, Rachel Erlich, PhD^1*, Phil Stephens, PhD^1*, Vincent A. Miller, MD^1*, Jo-Anne Vergilio, MD^1* and Tariq I Mughal, MD^1,3

¹Foundation Medicine, Inc., Cambridge, MA
²Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
³Tufts Medical Center, Cambridge, MA

Zoran Gatalica, MD, PhD^1*, Nurija Bilalovic, MD, PhD^2*, Semir Vranic, MD, PhD^2*, David Arguello, MD^1*, Sandeep Reddy, MD^1* and Nilanjan Ghosh, MD, PhD³

¹Caris Life Sciences, Phoenix, AZ
²University of Sarajevo, Sarajevo, Bosnia
³Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC

Huimin Geng, PhD^1*, Zhengshan Chen, Ph.D.^1*, Shawn Anderson^2*, Eleanor Fraser, PhD^3*, Ming Lu^3*, Chen Lingjing, Ph.D.^3*, Colin Collins, Ph.D.^2*, Muschen Markus, Ph.D.^1* and James L. Rubenstein, MD, PhD⁴

¹Laboratory Medicine, University of California, San Francisco, San Francisco, CA
²University of British Columbia, Vancouver, BC, Canada
³Medicine, University of California, San Francisco, San Francisco, CA
⁴Division of Hematology and Oncology, University of California, San Francisco, San Francisco, CA

Sabine Jeromin, PhD^*, Wolfgang Kern, MD, Torsten Haferlach, Susanne Schnittger, PhD and Claudia Haferlach, MD

MLL Munich Leukemia Laboratory, Munich, Germany

Alba Navarro^1*, Guillem Clot^2*, Alejandra Martinez-Trillos^3*, Itziar Salaverria^1*, David Martin-Garcia^1*, Nicola Trim^4*, Veronica Fernandez^2*, Neus Villamor⁵, Dolors Colomer^5*, Magda Pinyol^6*, Pedro Jares^6*, Wendy N. Erber⁷, Adrian Wiestner⁸, Wyndham H. Wilson, MD, PhD⁹, Reiner Siebert, MD^10*, Marta Aymerich^5*, Armando Lopez-Guillermo¹¹, Àlex Sánchez^12*, Elias Campo¹³, Estella Matutes^3* and Sílvia Beà^1*

¹Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
²Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Barcelona, Spain
³Hematopathology Unit, Hospital Clinic, Barcelona, Spain
⁴West Midlands Regional Genetics Laboratory, Birmingham, United Kingdom
⁵Hospital Clínic, Barcelona, Spain
⁶Genomics Unit, IDIBAPS, Barcelona, Spain
⁷Pathology, University of Western Australia, Crawley, Australia
⁸Hematology Branch, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD
⁹National Cancer Institute, Bethesda, MD
¹⁰Institute of Human Genetics, Christian-Albrechts-University Kiel, Kiel, Germany
¹¹Hematology, Hospital Clinic, Barcelona, Spain
¹²Department of Statistics, University of Barcelona, Barcelona, Spain
¹³Hematophatology Unit, Hospital Clinic, Barcelona, Spain

Christopher Daniel Carey, M.D.,^1*, Daniel Gusenleitner, MS^2*, Zhang Xuan, BA^3*, Aliyah R Sohani, MD⁴, Olga Weinberg, MD^5*, Hongbo Yu, MD^6*, Ben Chen, MD, PhD^6*, Bruce Woda, MD⁶, Kai Fu, MD, PhD⁷, Stefano Monti, PhD^2* and Scott J. Rodig, M.D., Ph.D.⁸

¹Department of Pathology, Brigham & Women's Hospital, Boston, MA
²Section of Computational Biomedicine, Boston University School of Medicine, Boston, MA
³University of Nebraska Medical School, Omaha, NE
⁴Department of Pathology, Massachusetts General Hospital, Boston, MA
⁵Boston Children's Hospital, Boston, MA
⁶University of Massachusetts Memorial Medical Center, Worcester, MA
⁷Department of Pathology and Microbiology and Internal Medicine, University of Nebraska Medical Center, Omaha, NE
⁸Department of Pathology, Brigham & Women's Hospital, Harvard Medical School, Boston, MA

Fengjie Guo, PhD^1,2*, Xiaoyu Jiang, PhD^1,2*, Domenico Roberti^3*, Lixin Rui, PhD⁴ and Izidore S Lossos, MD^1,2

¹Division of Oncology-Hematology, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL
²Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL
³Department of Pathology, Laura and Isaac Perlmutter Cancer Center, New York University School of Medicine, New York, NY
⁴Department of Medicine and Carbone Cancer Center, University of Wisconsin School of Medicine and Public Health, Madison, WI

Chan Yoon Cheah, MBBS DMedSc^1,2,3,4, Martin Hutchings, MD^5*, Kirsty Rady, MBBS^6*, Kerry J. Savage, MD, MSc⁷, Musa F. Alzahrani, MBBS, ABIM⁸, Laurie H. Sehn⁹, Sally Barrington, MD^10*, George Mikhaeel, MD^11*, Roopesh R. Kansara, MD¹², Jakob Werner Hansen, MD^13*, Daniel Smith, MD^14*, Karen Juul Mylam, MD^15*, Thomas Stauffer Larsen, MD, PhD^16*, Staffan Holmberg, MD^17*, Maja Juul, MD^18*, Sabrina Cordua, MD¹⁹, Michael Roost Clausen, MD^20*, Kkristina Buchardi Jensen^21*, Martin Bogsted^22*, Hans Erik Johnsen, Professor, MD²³, Joseph M. Connors, MD⁹, Peter de Nully Brown²⁴, John F. Seymour, MBBS, PhD^25,26, Diego Villa, MD, MPH⁷ and Tarec Christoffer El-Galaly^27*

¹School of Pathology and Laboratory Medicine, University of Western Australia, Perth, Australia
²Department of Haematology, Sir Charles Gairdner Hospital, Perth, Australia
³Department of Haematology, Pathwest Laboratory Medicine WA, Perth, Australia
⁴Department of Haematology, Peter MacCallum Cancer Centre, Melbourne, Australia
⁵Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
⁶Department of Haematology, Peter MacCallum Cancer Centre, East Melbourne, Australia
⁷BC Cancer Agency and University of British Columbia, Centre for Lymphoid Cancer, Vancouver, BC, Canada
⁸Department of Hematology, Faculty of Medicine, University of British Columbia, University of British Columbia, Vancouver, BC, Canada
⁹British Columbia Cancer Agency, Centre for Lymphoid Cancer and Department of Medical Oncology, Vancouver, BC, Canada
¹⁰Guy's and St. Thomas' Hospital and Kings College, London, United Kingdom
¹¹Medical Oncology, Guy's and St Thomas' NHS Trust, London, United Kingdom
¹²Centre for Lymphoid Cancer and Division of Medical Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada
¹³Department of Haematology, Rigshospitalet, Copenhagen, Denmark
¹⁴Guy's and St Thomas' NHS Trust, London, United Kingdom
¹⁵Department of Haematology, Odense Univsersity Hospital, Odense, Denmark
¹⁶Department of Hematology, Odense University Hospital, Odense, Denmark
¹⁷Department of Haematology, Herlev Hospital, Copenhagen, Denmark
¹⁸Department of Haematology, Vejle Hospital, Vejle, Denmark
¹⁹Department of Hematology, Roskilde University Hospital, Roskilde, Denmark
²⁰Hematology, Aarhus University Hospital, Aarhus, Denmark
²¹Department of Haematology, Holstebro Hospital, Holstebro, Denmark
²²Unit of Biostatistics, Aalborg University Hospital, Aalbord, Denmark
²³Department of Haematology, Aalborg University Hospital, Aalborg, Denmark
²⁴Department of Oncology, Copenhagen University Hospital, Copenhagen, Denmark
²⁵Peter MacCallum Cancer Centre, Melbourne, Australia
²⁶University of Melbourne, Melbourne, Australia
²⁷Department of Hematology, Aalborg University Hospital, Aalborg, Denmark

Cassandra Love^1*, Rachel Remple, PhD^1*, Guojie Li, PhD^1* and Sandeep Dave, MD²

¹Duke University, Durham, NC
²Duke Cancer Institute, Duke University Medical Center, Durham, NC

Nitin Agarwal, PhD^1*, Chae Hwa Kim, MD^1*, Kranthi Kunkalla, MS^1*, Gloria Yang^1*, Youley Tjendra, MD^1*, Yadong Liu, MD^2*, Changju Qu, MD PhD^3* and Francisco Vega, MD, PhD¹

¹Department of Pathology and Laboratory Medicine, Division of Hematopathology, University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center, and Jackson Memorial Hospital, Miami, FL
²General Surgery, Min'ai Clinic, Shenzhen, China
³Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China

Manabu Kusakabe, MD, PhD¹, Xuehai Wang, PhD^1*, Guillermo Simkin, PhD^1*, Justin Meskas, MSc^1*, Chaoran Zhang^1*, Daisuke Ennishi, MD, PhD,^2*, Robert Kridel, MD, MPH², Merrill Boyle, BSc^2*, Elizabeth Chavez, BSc^2*, Stacy Hung, PhD^2*, David W Scott, MBChB, PhD², Christian Steidl, MD², Randy D. Gascoyne³, Ryan R. Brinkman, PhD^1* and Andrew P Weng, MD, PhD¹

¹Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada
²Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC, Canada
³British Columbia Cancer Agency, Vancouver, BC, Canada

Annapurna Saksena, MD^1*, Parth Desai, MD^2*, Zhuang Zuo, MD, PhD^3*, Jie Xu, MD^4*, Pei Lin, MD³, Adam C. Seegmiller, MD, PhD^5*, C. Cameron Yin, MD, PhD³, Guilin Tang, MD,^6*, Roberto N. Miranda, MD³, Jeffrey L. Jorgensen, MD, PhD³, Nishitha M Reddy, M.B.B.S.⁷, L. Jeffrey Medeiros⁸ and Shaoying Li, MD^6*

¹MD Anderson Cancer Center, Houston, TX
²Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴MD Anderson Cancer Center, Houston
⁵Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN
⁶Department of Hematopathology, MD Anderson Cancer Center, Houston, TX
⁷Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN
⁸Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX

Rajan Dewar, MD, PhD^1,2*, Julia Friedman, Ph.D.^3*, Daniel Xia, MD^1*, Timothy George Lens^4*, Asha Guttapalli, M.Sc.^3*, Phillip Michaels, MD^1*, Venkata Thodima, Ph.D.^3*, Sitharthan Kamalakaran, Ph.D.^3*, Jane Houldsworth, Ph.D.³ and Robin Joyce, MD⁴

¹Department of Pathology, Harvard Medical School and Beth Israel Deaconess Medical Center, Boston, MA
²Department of Pathology, University of Michigan, Ann Arbor, MI
³Cancer Genetics, Inc., Rutherford, NJ
⁴Division of Hematology and Oncology, Harvard Medical School and Beth Israel Deaconess Medical Center, Boston, MA

Nozomi Niitsu, MD, PhD.¹, Naoki Takahashi^1*, Tadashi Yoshino, MD, PhD^2*, Masataka Okamoto, MD, PhD^2* and Shigeo Nakamura, MD, Ph.D.²

¹Department of Hematology, International Medical Center, Saitama Medical University, Hidaka, Japan
²Adult Lymphoma Treatment Study Group (ALTSG), Nagoya, Japan

Russell Patmore, MRCP FRCPath¹, Alexandra Smith^2*, Burton Cathy^3*, Eve Roman^2* and Simon Crouch, PhD^4*

¹Queens Centre for Oncology and Hematology, Castle Hill Hospital, Hull, United Kingdom
²Epidemiology and Cancer Statistics Group, University of York, York, United Kingdom
³Haematological Malignancy Diagnostic Service, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
⁴Epidemiology & Cancer Statistics Group, University of York, York, United Kingdom

Guilherme Fleury Perini, MD^1*, Joao Garibaldi Junior, MD^1*, Adriana M. Damasco Penna, M.D^2*, Marina P Cristelli^3*, Adriana Bruscato^3*, Egyla M Cavalcanti, MD^1*, Jose Osmar Medina Pestana, MD^3*, Gisele W. B. Colleoni^4*, Jose Pedro Zampieri Filho, MD^1*, Rodrigo Vaez^1*, Otavio C. G. Baiocchi^1* and Jose Orlando Bordin, MD, PhD⁵

¹Hematology Department, Universidade Federal de Sao Paulo (UNIFESP), Sao Paulo, Brazil
²Disciplina de Hematologia e Hemoterapia, Universidade Federal de São Paulo, São Paulo, Brazil
³Hospital do Rim, Universidade Federal de Sao Paulo (UNIFESP), Sao Paulo, Brazil
⁴Federal University of Sao Paulo, Sao Paulo, Brazil
⁵Disciplina de Hematologia e Hemoterapia, Universidade Federal de São Paulo, Sao Paulo, Brazil

Kalyan Mantripragada, MD, MPH^1*, Jorge J Castillo, MD² and Adam J Olszewski, MD³

¹Department of Medicine, Alpert Medical School of Brown University, Providence, RI
²Division of Hematologic Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
³Division of Hematology-Oncology, Alpert Medical School of Brown University, Providence, RI

Kota Fukumoto, MD^*, Manabu Fujisawa, MD^*, Yasuhito Suehara, MD^*, Yoshiaki Usui, MD^*, Kentaro Narita, MD^*, Masami Takeuchi, MD^* and Kosei Matsue, MD/PhD

Division of Hematology/Oncology, Department of Medicine, Kameda Medical Center, Kamogawa city, Japan

Ambroise Marçais, MD^1,2*, Katia Hanssens^3*, Laetitia Waast^1*, Vahid Asnafi, MD PhD^4*, Philippe Gaulard, MD, PhD^5,6*, Felipe Suarez, MD, PhD^7,8, Laurence Benit^1*, Patrice Dubreuil^3*, Antoine Gessain^9*, Claudine Pique^1* and Olivier Hermine^10,11*

¹Institut Cochin Unité 1016, Paris, France
²Institut Imagine, Paris, France
³Inserm U1068, Centre de Recherche en Cancérologie de Marseille, Institut Paoli-Calmettes, Université de la Méditerranée, Marseille, France
⁴Université Paris Descartes Sorbonne Cité, Institut Necker-Enfants Malades (INEM), Institut national de recherche médicale (INSERM) U1151, and Laboratory of Onco-Hematology, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Necker Enfants-Malades, Paris, Paris, France
⁵EQ 9, INSERM U955, CRETEIL, France
⁶department of pathology, APHP, Groupe Hospitalier Mondor, CRETEIL, France
⁷Paris Descartes Sorbonne Paris Cite University, Paris, France
⁸Hematologie, Hopital Necker, Assistance Publique-Hopitaux de Paris French Ref. Ctr. for Prima, Paris, France
⁹Unité d’épidémiologie et Physiopathologie des Virus Oncogènes, Département de Virologie, CNRS, UMR 3569, Institut Pasteur, Paris, France, Paris, France
¹⁰Imagine Institute, Sorbonne Paris Cité, Paris Descartes University, Paris, France
¹¹Department of Hematology, Necker Children's hospital, APHP, Paris, France

Sylvain P Chantepie, MD^1*, Narinée Hovhannisyan^2*, Stéphane Guillouet^2*, Alain Manrique, MD, PhD^3*, Oumedaly Reman, MD⁴, Louisa Barre^2* and Michel Leporrier, MD, PhD⁵

¹Department of Hematology, University Hospital, Caen, France
²CEA, DSV/I2BM, LDM-TEP Group, GIP Cyceron, Caen, France
³Imagerie chez l'Homme, GIP Cyceron, Caen, France
⁴Department of Hematology, Caen University Hospital, Caen, France
⁵GIP Cyceron, CEA, DSV/I2BM, LDM-TEP Group and University of Basse-Normandie, Caen, France

Jin-Hua Liang^1*, Chong-Yang Ding^2*, Li Wang^1*, Lei Fan, MD., PhD.^1*, Tian-Nv Li^2*, Jian-Yong Li, MD, PhD¹ and Wei Xu^1*

¹Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China
²Department of Nuclear Medicine, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing 210029, China, Nanjing, China

Michel Meignan^1*, Annibale Versari, MD^2*, Anne Ségolène Cottereau^1*, Loïc Chartier^3*, Jehan Dupuis, MD^4*, Sami Boussetta^3*, Ilaria Grassi^2*, Rene-Olivier Casasnovas, MD^5*, Corinne Haioun, MD, PhD⁶, Hervé Tilly, MD, PhD⁷, Massimo Federico⁸, Gilles A. Salles, MD, PhD⁹, Stefano Luminari, MD^10* and Judith Trotman, MBChB¹¹

¹CHU Henri Mondor, Créteil, France
²Santa Maria Nuova Hospital, Reggio Emilia, Italy
³Department of Biostatistics, LYSARC Centre Hospitalier Lyon Sud, Lyon, France
⁴Lymphoid Malignancies Unit, APHP, Groupe Hospitalier Mondor, CRETEIL, France
⁵Hematology, University Hospital, Dijon, France
⁶Lymphoid Malignancies Unit, CHU Henri Mondor, Créteil, France
⁷INSERM U918, Centre Henri Becquerel, Rouen, France
⁸Department of Diagnostic and Clinical Medicine, and Public Health, University of Modena and Reggio Emilia, Modena, Italy
⁹Hospices Civils de Lyon, University Claude Bernard, Pierre-Benite, France
¹⁰Department of Diagnostic, Clinical and Public Health Medicine, University of Modena and Reggio Emilia, Modena, Italy
¹¹University of Sydney, Concord, Australia

Gaëlle Labouré^1*, Marie-Cécile Parrens, MD^2*, Anjarasoa Tsaranazy^3*, Magali Bordier^2*, Steven Le Gouill, MD, PhD^4*, Vincent Delwail, MD^5*, Remy Gressin, MD⁶, Jérôme Cornillon, MD^7*, Gandhi Damaj, MD, PhD⁸, Charles Yves Foussard, MD⁹, Herve Maisonneuve, MD^10*, Eric Deconinck, MD, PhD¹¹, Guillaume Cartron, MD, PhD^12*, Francois Dreyfus, MD^13*, Emmanuel Gyan, MD, PhD¹⁴, Laurent Sutton, MD^15*, Nadine Morineau, MD^16*, Magda Alexis^17*, Anne Banos, MD^18*, Diane Damotte, MD, PhD^19*, Anne Moreau, MD^20*, Françoise Kraeber-Bodéré, MD, PhD^21*, Delphine Rossille, PhD^22*, Thierry Fest, MD, PhD^23*, Thierry Lamy, MD, PhD²⁴ and Noel Milpied, MD, PhD²⁵

¹Hematology Department, CHU Bordeaux, Pessac, France
²Pathology Department, CHU Bordeaux, Pessac, France
³Statistics Department, CHU Bordeaux, Pessac, France
⁴Department of Hematology, Nantes University Hospital, Nantes, France
⁵Hematology Department, CHU Poitiers, Poitiers, France
⁶Service d'hématologie clinique, CHU Grenoble, Grenoble, France
⁷Department of Hematology, Saint-Etienne University Hospital, Saint-Etienne, France
⁸Hematology Department, CHU Caen, Caen, France
⁹Hematology Department, CHU Angers, Angers, France
¹⁰Oncology and Hematology Department, CH, La Roche-sur-Yon, France
¹¹Department of Hematology, CHU Besancon, Besancon, France
¹²Department of Clinical Hematology, University Hospital of Montpellier, Montpellier, France
¹³CHU Cochin, Hematology, Paris, France
¹⁴Department of Clinical Hematology, CHRU de Tours, Tours, France
¹⁵Hematology Department, Argenteuil Hospital, Argenteuil, France
¹⁶Hematology Department, Centre Catherine de Sienne Nantes, Nantes, France
¹⁷Hematology Department, CHR Orleans, Orleans, France
¹⁸Hematology Department, CH Cote basque, Bayonne, France
¹⁹Pathology Department, CHU Cochin Paris, Paris, France
²⁰Department of Pathology, Nantes University Hospital, Nantes, France
²¹Nuclear Medicine Department, CHU Nantes, Nantes, France
²²CHU Rennes, Rennes, France
²³INSERM U917 - CHU de Rennes, Rennes, France
²⁴Haematology, CHU Pontchaillou, Rennes, France
²⁵CHU de Bordeaux, Bordeaux, France

Lakshmi Suryateja Gangavarapu^1* and Rakesh Surapaneni, MD²

¹Westwood High school, Round Rock
²Scott and White Health Care, Temple, TX

Bjoern Chapuy, MD PhD¹, Andrew J Dunford, BS^2*, Chip Stewart, PhD^2*, Atanas Kamburov, PhD^2*, Jaegil Kim, PhD^2*, Margaretha GM Roemer, MS^1*, Marita Ziepert, PhD^3*, Amy Jiayue Li^4*, Mike Lawrence, PhD^2*, Julian Hess, BS^2*, Mara Rosenburg, BS^2*, Amaro N Taylor-Weiner, BS^2*, Robert A Redd, MS^5*, Heike Horn, PhD^6*, Anne Novak, PhD⁷, James R Cerhan, MD PhD⁷, Thomas M Haberman, MD^7*, Andrew L Feldman, MD⁷, Brian K Link, MD⁸, Todd R Golub, MD², Donna S Neuberg, ScD⁹, German Ott, MD^10*, Reiner Siebert, MD^11*, Andreas Rosenwald, MD^12*, Gerald G Wulf, MD¹³, Stefano Monti, PhD^4*, Scott J Rodig, MD, PhD¹⁴, Markus Löffler, PhD^3*, Michael Pfreundschuh, MD¹⁵, Lorenz Trümper, MD^13*, Gad Getz, PhD^2* and Margaret A. Shipp, MD¹⁶

¹Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
²Broad Institute, Cambridge, MA
³Institute for Medical Informatics, Statistics, and Epidemiology, University of Leipzig, Germany, Leipzig, Germany
⁴Section of Computational Biomedicine, Boston University School of Medicine, Boston, MA
⁵Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA
⁶Dr. Margarete Fischer-Bosch Institute for Clinical Pharmacology and University of Tübingen, Stuttgart, Germany
⁷Mayo Clinic, Rochester, MN
⁸Division of Hematology, Oncology and Blood & Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, IA
⁹Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA
¹⁰Department of Clinical Pathology, Robert-Bosch-Krankenhaus, Stuttgart, Germany
¹¹Institute of Human Genetics, Christian-Albrechts-University Kiel, Kiel, Germany
¹²University of Würzburg, Würzburg, Germany
¹³Hematology and Oncology, University Hospital of Göttingen, Göttingen, Germany
¹⁴Pathology, Brigham and Women's Hospital, Boston, MA
¹⁵Department of Hematology and Oncology, University Clinic of Saarland, Homburg, Germany, Homburg/Saar, Germany
¹⁶Dana-Farber Cancer Institute, Boston, MA

Michael W Bösl^1*, Elisa Osterode^1*, Deepak Bararia, PhD^1*, Alessandro Pastore, MD^1*, Anette M Staiger^2*, German Ott, MD^3*, Monika Szczepanowski, PhD^4*, Wolfram Klapper, MD^4*, Andreas Rosenwald, MD^5*, Wolfgang Hiddemann, MD¹ and Oliver Weigert, MD¹

¹Department of Internal Medicine III, Ludwig-Maximilians University of Munich, Munich, Germany
²Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany
³Department of Clinical Pathology, Robert-Bosch-Krankenhaus, Stuttgart, Germany
⁴Hematopathology Section, Christian-Albrechts-University Kiel, Kiel, Germany
⁵University of Würzburg, Würzburg, Germany

Niamh Appleby^1*, Ruth Cullen^1*, Dan Painter^2*, Alexandra Smith^2*, Eve Roman^2*, Sharon Barrans, PhD^3*, Sheila J.M. O'Connor^4*, Catherine H Burton^1*, Andrew S Jack⁴, Roger G Owen¹ and Reuben M Tooze, PhD, FRCP^5,6

¹St James's University Hospital, Haematological Malignancy Diagnostic Service (HMDS), Leeds, United Kingdom
²Epidemiology and Cancer Statistics Group, University of York, York, United Kingdom
³St James Institute of Oncology, HMDS, Leeds, United Kingdom
⁴HMDS, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
⁵HMDS, Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
⁶Section of Experimental Haematology, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, United Kingdom

Abner Louissaint Jr., MD, PhD^1,2, Kristian T. Schafernak, MD, MPH³, Julia T. Geyer, MD^4*, Alexandra E. Kovach, MD^5*, Dita Gratzinger, MD, PhD⁶, Christine G. Roth, MD⁷, Christian N. Paxton, PhD^8*, Sunhee Kim^2*, Chungdak Namgyal^9*, Elizabeth A. Morgan, MD⁹, Sarah T. South, PhD^8,10*, Marian H. Harris, MD, PhD^5*, Ephraim P. Hochberg, MD¹¹, Robert P. Hasserjian, MD¹, Nancy L. Harris, MD^1* and David M. Weinstock, MD²

¹Department of Pathology, Massachusetts General Hospital, Boston, MA
²Dana-Farber Cancer Institute, Boston, MA
³Department of Pathology and Laboratory Medicine, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL
⁴Department of Pathology and Laboratory Medicine, Weill Cornell Medical College/NewYork-Presbyterian Hospital, New York, NY
⁵Department of Pathology, Boston Children's Hospital, Boston, MA
⁶Department of Pathology, Stanford University School of Medicine, Stanford, CA
⁷Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA
⁸ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT
⁹Department of Pathology, Brigham and Women's Hospital, Boston, MA
¹⁰Department of Pathology, University of Utah, Salt Lake City, UT
¹¹Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA

Josephine M. Vos, MD^1,2*, Robert R Manning^1*, Kirsten Meid, MPH^1*, Joshua Gustine, MPH^1*, Christopher J Patterson, MFA^1*, Philip Brodsky^1*, Sandra Kanan, NP, RN, MSN^1*, Marie José Kersten, MD, PhD³, Steven P Treon, MD, PhD¹ and Jorge J Castillo, MD⁴

¹Bing Center for WM, Dana Farber Cancer Institute, Boston, MA
²Internal Medicine/Hematology, St. Antonius Ziekenhuis, Nieuwegein, Netherlands
³Department of Hematology, Academic Medical Center, Amsterdam, Netherlands
⁴Division of Hematologic Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA